Latest News
Featured News
Scancell announces CFO Transition
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 10-12 December 2025 in London
Latest SCOPE data confirm durable improvement
Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+
Abundant development opportunities in immuno-oncology
Scancell to present positive Phase 2 data on Immunobody® iSCIB1+ in late-stage melanoma at SITC 2025
Interim Report 31st October 2025
Results of 2025 Annual General Meeting
Notice of Annual General Meeting
Notice of Annual General Meeting October 2025
Director Dealing
Presentation of Year End Results: 11 September 2025
Scancell CEO on 2025 Milestones and Road ahead
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.